Fliser D - Search Results

1

Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.

Humalda JK, Seiler-Muler S, Kwakernaak AJ, Vervloet MG, Navis G, Fliser D, Heine GH, de Borst MH. Humalda JK, et al. Among authors: fliser d. Medicine (Baltimore). 2016 Nov;95(46):e5003. doi: 10.1097/MD.0000000000005003. Medicine (Baltimore). 2016. PMID: 27861335 Free PMC article. Clinical Trial.

2

Clinical relevance of FGF-23 in chronic kidney disease.

Seiler S, Heine GH, Fliser D. Seiler S, et al. Among authors: fliser d. Kidney Int Suppl. 2009 Dec;(114):S34-42. doi: 10.1038/ki.2009.405. Kidney Int Suppl. 2009. PMID: 19946326 Free article. Review.

3

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.

Seiler S, Reichart B, Roth D, Seibert E, Fliser D, Heine GH. Seiler S, et al. Among authors: fliser d. Nephrol Dial Transplant. 2010 Dec;25(12):3983-9. doi: 10.1093/ndt/gfq309. Epub 2010 Jun 3. Nephrol Dial Transplant. 2010. PMID: 20525642

4

FGF-23: the rise of a novel cardiovascular risk marker in CKD.

Heine GH, Seiler S, Fliser D. Heine GH, et al. Among authors: fliser d. Nephrol Dial Transplant. 2012 Aug;27(8):3072-81. doi: 10.1093/ndt/gfs259. Nephrol Dial Transplant. 2012. PMID: 22851630 Review.

5

Calcium and phosphate impact cardiovascular risk.

Heine GH, Nangaku M, Fliser D. Heine GH, et al. Among authors: fliser d. Eur Heart J. 2013 Apr;34(15):1112-21. doi: 10.1093/eurheartj/ehs353. Epub 2012 Oct 28. Eur Heart J. 2013. PMID: 23109644 Review.

6

Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.

Emrich IE, Brandenburg V, Sellier AB, Schauerte J, Wiedenroth J, Untersteller K, Lennartz CS, Seiler-Mussler S, Wagenpfeil S, Fliser D, Heine GH. Emrich IE, et al. Among authors: fliser d. Am J Nephrol. 2019;49(3):203-211. doi: 10.1159/000497125. Epub 2019 Feb 26. Am J Nephrol. 2019. PMID: 30808827

7

The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.

Seiler S, Cremers B, Rebling NM, Hornof F, Jeken J, Kersting S, Steimle C, Ege P, Fehrenz M, Rogacev KS, Scheller B, Böhm M, Fliser D, Heine GH. Seiler S, et al. Among authors: fliser d. Eur Heart J. 2011 Nov;32(21):2688-96. doi: 10.1093/eurheartj/ehr215. Epub 2011 Jul 6. Eur Heart J. 2011. PMID: 21733911

8

Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.

Seiler S, Wen M, Roth HJ, Fehrenz M, Flügge F, Herath E, Weihrauch A, Fliser D, Heine GH. Seiler S, et al. Among authors: fliser d. Kidney Int. 2013 Jan;83(1):121-8. doi: 10.1038/ki.2012.288. Epub 2012 Aug 15. Kidney Int. 2013. PMID: 22895520 Free article.

9

Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.

Seiler S, Rogacev KS, Roth HJ, Shafein P, Emrich I, Neuhaus S, Floege J, Fliser D, Heine GH. Seiler S, et al. Among authors: fliser d. Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1049-58. doi: 10.2215/CJN.07870713. Epub 2014 Mar 27. Clin J Am Soc Nephrol. 2014. PMID: 24677555 Free PMC article.

10

Ferric pyrophosphate: good things come to those who wait?

Fell LH, Fliser D, Heine GH. Fell LH, et al. Among authors: fliser d. Nephrol Dial Transplant. 2015 Dec;30(12):1942-4. doi: 10.1093/ndt/gfv287. Epub 2015 Jul 21. Nephrol Dial Transplant. 2015. PMID: 26203048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page